Gene fusions prevalent in prostate cancer (CaP) lead to the elevated expression of the ERG proto-oncogene. ERG activation present in 50–70% of prostate tumors underscores one of the most common ...

An interview with Dr. Anil Parwani, discusses how whole slide imaging of prostate cancer sections is helping to inform pathologists and improve patient outcomes. Prostate cancer is often a devastating ...

Researchers have identified three new prostate cancer biomarkers that improve the visibility of cancer cells used by pathologists to grade the disease’s severity. The novel technique could assist in ...

Deep Bio and Techcyte expand digital pathology with AI-powered prostate and frozen section solutions on the Fusion® platform. By combining Deep Bio's advanced algorithms with our digital workflows, we ...

What Is a Prostate Exam? A prostate exam is a test that checks for early signs of prostate cancer. It doesn't reveal cancer, but if the test shows an abnormal result, your doctor will likely need to ...

OREM, UT, UNITED STATES, August 26, 2025 /EINPresswire.com/ -- Deep Bio, a global leader in AI-powered cancer diagnostics, today announced a strategic partnership ...